Navigation Links
National Safety Council Launches June National Safety Month With Free Training
Date:5/26/2009

ITASCA, Ill., May 26 /PRNewswire-USNewswire/ -- The National Safety Council will launch its 2009 June National Safety Month with free enrollment in two popular online training courses, June 1-7 only:

  • "Alive at 25(R) Parent Program," for parents of teen drivers, and
  • "First Aid and CPR with AED," basic training for adults.

The "Alive at 25 Parent Program" is an engaging, science-based course that educates parents about the risks teen drivers face. Through this two-hour online program, parents will learn how to reinforce basic driving skills and good decision-making that can help teens become safe and responsible drivers. Registration is free June 1-7 only at www.parentprogram25.com/NSM. (Click on "New Student" and enter "NSM" as an access code. Users will have 30 days to complete the program.)

"First Aid and CPR with AED" is a three-hour online course that can make the difference between life and death. Every year 1.1 million people in the U.S. have a heart attack and about half of them die. Many of these people could be saved if help came faster. Through this course, offered in conjunction with National CPR/AED Week, users will learn the latest method of cardiopulmonary resuscitation (CPR) and how to use an automated external defibrillator (AED), as well as how to help a person who is choking. First aid topics include bleeding, wound care, shock, burns, serious injuries, fractures and sprains. To register for free June 1-7 only, visit: www.nscfirstaid.com/nationalCPRweek.

Both courses are available all year, with a registration fee, at nsc.org.

National Safety Month is the NSC's annual campaign to educate people about some of our nation's leading causes of preventable death
'/>"/>

SOURCE National Safety Council
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BioFit Names Rusty Benschoter National Sales & Marketing Manager
2. National Federation of the Blind Congratulates NASA on Successful Mission
3. New National Day and Scholarship Created in Celebration of Healthcare Professionals
4. Statement of National Business Group on Health
5. Bill Saunders Joins Americans United for Life, Set to Expand Efforts to Protect Human Life Internationally
6. National Eyewear Chain Visionworks Opens Two New Stores in Orlando Market
7. National Eyewear Chain EyeMasters Opens Tenth Store in Cleveland Market
8. National Medical Interpreter Certification Testing Enters Pilot Phase
9. National Pharmacy Omnicare Pays 'Unusual' Settlement to Resolve Charges of Generic Drug Switching in Delaware Nursing Homes, Resulting From 'Qui Tam' Lawsuit
10. An International Design Team has Been Selected for an Iraqi Hospital to Transform Healthcare in the Middle East
11. APHA Joins National Coalition in Issuing Transportation Reform Blueprint
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 2Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 3Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 5Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 6Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 7TCT 2009 to Feature vProtect 28TM 29 Luminal Shield a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical 14134 1TCT 2009 to Feature vProtect 28TM 29 Luminal Shield a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical 14134 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 1Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 4Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 5Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 6Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 7